Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment

Emergency use authorization of drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by regulatory authorities has provided new options to treat high-risk outpatients with mild-to-moderate Coronavirus disease 2019 (COVID-19). We conducted an ambispective cohort study of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasagna, Angioletta, Cassaniti, Irene, Lilleri, Daniele, Quaccini, Mattia, Ferrari, Alessandra, Sacchi, Paolo, Bruno, Raffaele, Baldanti, Fausto, Pedrazzoli, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643502/
https://www.ncbi.nlm.nih.gov/pubmed/36388947
http://dx.doi.org/10.3389/fmed.2022.1036473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643502/
https://www.ncbi.nlm.nih.gov/pubmed/36388947
http://dx.doi.org/10.3389/fmed.2022.1036473

Ejemplares similares